| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0036 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.01 | 1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |